(Q48026223)

7 February 2018

title

Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study. (English)

1 reference

7 February 2018

main subject

type-1 diabetes

0 references

author

FinnDiane Study Group

13

1 reference

7 February 2018

N Tolonen

1

1 reference

7 February 2018

K Hietala

2

1 reference

7 February 2018

C Forsblom

3

1 reference

7 February 2018

V Harjutsalo

4

1 reference

7 February 2018

V-P Mäkinen

5

1 reference

7 February 2018

J Kytö

6

1 reference

7 February 2018

P A Summanen

7

1 reference

7 February 2018

L M Thorn

8

1 reference

7 February 2018

J Wadén

9

1 reference

7 February 2018

D Gordin

10

1 reference

7 February 2018

M-R Taskinen

11

1 reference

7 February 2018

P-H Groop

12

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 August 2013

1 reference

7 February 2018

Journal of Internal Medicine

published in

1 reference

7 February 2018

volume

274

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

page(s)

469-479

1 reference

7 February 2018

Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Lipids and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Relationship between lipid profiles and kidney function in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Effects of medical therapies on retinopathy progression in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Non-invited review: prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Implementation of guidelines for the prevention of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Can clinical factors estimate insulin resistance in type 1 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12111

21 January 2018

Identifiers

DOI

10.1111/JOIM.12111

1 reference

7 February 2018

PubMed ID

23844944

1 reference

7 February 2018